Ignite Creation Date:
2024-05-05 @ 9:46 PM
Last Modification Date:
2024-10-26 @ 10:09 AM
Study NCT ID:
NCT00955552
Status:
COMPLETED
Last Update Posted:
2023-02-08
First Post:
2009-08-05
Brief Title:
Efficacy and Safety Study of GlucosamineChondroitin Sulfate to Patients Treatment With Osteoarthrosis of the Knee
Sponsor:
Eurofarma Laboratorios SA
Organization:
Eurofarma Laboratorios SA
Study Overview
Official Title:
A Multi-center Randomized Double Blind Comparative of Efficacy and Safety From Association of Capsules Glucosamine and Chondroitin Sulfate Eurofarma Versus Cosamin DS to Treatment With Osteoarthrosis of the Knee
Status:
COMPLETED
Status Verified Date:
2022-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Artico
Brief Summary:
The purpose of this study is to assess the efficacy and safety of glucosamine and chondroitin sulfate association in the treatment of patients with osteoarthrosis of the knee
Detailed Description:
To assess the efficacy and safety of the association of glucosamine sulphate 500 mgchondroitin sulphate 400 mg Eurofarma in the treatment of osteoarthritis compared to Cosamin DS Nutramax in same presentation and pharmaceutical form
Some eligibility criteria
Osteoarthritis of the knee confirmed by radiological examination Visual analogue scale VAS 40 mm Clinical diagnosis of pain and functional limitation
Some eligibility criteria
Osteoarthritis of the knee confirmed by radiological examination Visual analogue scale VAS 40 mm Clinical diagnosis of pain and functional limitation
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None